Confessions of a GP - Benjamin Daniels [62]
There are many millions of people on benefits and they are costing the country billions of pounds. As a GP, I have a social responsibility to try to encourage people to work. This is partly for the good of the national economy and also because working is good for you. Evidence shows that working is beneficial to our physical health and mental wellbeing. I wish I could convey this to some of my patients on long-term sick leave. Some of my ‘disabled’ depressed patients are only in their early twenties and I know that they’ll probably never ever work. It is very sad and I don’t want to sound unsympathetic, but moping around at home watching daytime TV surely can’t be helping. When I have the energy, I do try to urge my patients to think about the positives of having a job and encourage them to get back to work. Sometimes, no matter how hard I try, they end up leaving with a sick note.
Drug reps…again
More of a moan about drug reps and the pharmaceutical industry’s cosy relationship with some doctors. I need to point out that most GPs have a healthy mistrust of the drug companies. An average GP might see a pharmaceutical rep once a week or so to find out about the new drugs on the market, but they take the presented information with a pinch of salt and are able to make their own minds up about the best drug to prescribe for their patients and the country’s health budget.
As I said earlier, most GPs now don’t get much more of an incentive to prescribe a specific drug than the odd free pen or egg sandwich. However, one or two GPs are still very much in the tight grip of the pharmaceutical companies and exhibit what I feel are blatant unethical collaborations that are not in the best interests of the patient at all. The following events happened at a surgery where I once worked.
DEXA scanners are bone scanners that look for osteoporosis. This is a disease caused by thinning of the bones that can occur in people from middle age onwards and can contribute to the likelihood of breaking a bone, particularly in later life. The scanner measures how dense the bone is. For those people at risk of having thin bones, the scanner can identify those who might benefit from taking calcium supplements and another type of medicine that can prevent bones from thinning further. These scans are available on the NHS and big studies have shown who is likely to be at risk and therefore which of our patients we should refer for scanning.
At the practice at which I was working, a drug company offered the senior partner a significant amount of money in order to allow them to scan our patients in the surgery with one of their mobile scanners. The mobile scanner is not as accurate as the big scanner that is available free of charge at the hospital. The senior partner phoned round many of her middle-aged, worried well patients and offered them a free scan at the surgery. Although they didn’t fit the criteria for being at risk of having osteoporosis, most of them jumped at the chance to have a free scan that would be conveniently done at the surgery. They also had all heard of osteoporosis and wanted to ensure that they weren’t at risk. The scanner appeared to overestimate how thin their bones were and therefore many of them were inaccurately diagnosed as having osteoporosis. These patients were then started on a medicine to keep their bones from supposedly deteriorating further. The senior partner was free to prescribe any medicine, but chose to prescribe the one that is made by the drug company that provided the scanner. This drug is considerably more expensive than other medications that are equally effective and costs the NHS £170 extra per year per patient.